Document Type

Journal Article

Publisher

SpringerOpen

Faculty

Faculty of Computing, Health and Science

School

School of Medical Sciences / Systems and Intervention Research Centre for Health

RAS ID

14460

Comments

This article was originally published as: Qian, M., Wu, D., Wang, E., Marincola, F., Wang, W. , Rhodes, W., Liebman, M., Bai, C., Lam, C., Marko-Varga, G., Fehniger, T., Andersson, R., & Wang, X. (2012). Development and promotion in translational medicine: perspectives from 2012 sino-american symposium on clinical and translational medicine. Clinical and Translational Medicine, 1(October), 1:25. Original article available here

Abstract

Background Clinical translational medicine (CTM) is an emerging area comprising multidisciplinary research from basic science to medical applications and entails a close collaboration among hospital, academia and industry. Findings This Session focused discussing on new models for project development and promotion in translational medicine. The conference stimulated the scientific and commercial communication of project development between academies and companies, shared the advanced knowledge and expertise of clinical applications, and created the environment for collaborations. Conclusions Although strategic collaborations between corporate and academic institutions have resulted in a state of resurgence in the market, new cooperation models still need time to tell whether they will improve the translational medicine process.

DOI

10.1186/2001-1326-1-25

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 2.0 License.

Share

 
COinS